Table 2 Group median (interquartile range Q1–Q3) of COV for within-session, between-session and between-scanner analysis per ROI per APT-weighted CEST metric.

From: Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners

COV of LD (%)

 

WM

GM

CSF

 

Within session

(N = 19)

0.56

[0.20–1.01]

0.68

[0.49–1.48]

3.04

[1.49–5.68]

 

Between session

(N = 6)

0.84

[0.38–1.27]

1.52

[0.72–2.41]

4.76

[3.74–6.70]

 

Between scanner

(N = 9)

0.80

[0.48–1.26]

1.28

[0.77–3.34]

6.62

[6.27–8.38]

 

All sessions (N = 6)

1.91

[1.08–3.17]

3.96

[2.30–7.13]

7.96

[6.16–8.33]

COV of MTRasym (%)

 

WM

GM

CSF

 

Within session

2.62

[0.94–7.08]

2.64

[1.35–7.00]

19.62

[7.14–35.90]

 

Between sessions

4.58

[3.48–9.66]

13.35

[9.40–19.99]

18.43

[3.86–47.32]

 

Between scanner

10.46

[2.69–15.72]

57.59

[32.81–68.53]

8.37

[3.27–31.11]

 

All sessions

12.22

[8.55–36.17]

49.47

[36.71–53.18]

35.28

[28.29–42.96]

COV of MTRREX (%)

 

WM

GM

CSF

 

Within session

1.28

[0.96–2.33]

2.34

[1.27–4.26]

3.94

[2.33–5.92]

 

Between sessions

0.79

[0.24–2.26]

4.48

[3.28–7.44]

9.98

[6.38–10.69]

 

Between scanner

9.30

[6.27–9.95]

8.85

[5.20–19.61]

10.98

[6.93–13.00]

 

All sessions

8.67

[6.98–9.57]

21.00

[15.33–26.65]

17.40

[13.87–18.58]